The 20 Best Gastrostomy Doctors Near Me

Find the Experts and Specialists who perform Gastrostomy

OverviewFind a DoctorLatest AdvancesClinical Trials
Haider Mahdi
Experienced in Gastrostomy

Dr. Haider Mahdi

Oncology
Corewell Health
Amal Gynecologic Oncology Clinic
2300 Haggerty Road, 
West Bloomfield, MI 
On Staff At
Clinical Trials:Currently Recruiting for 4 Trials
Accepting New Patients
22 Years of Experience
Experienced in Gastrostomy
Corewell Health
Amal Gynecologic Oncology Clinic
2300 Haggerty Road, 
West Bloomfield, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Haider Mahdi is an Oncologist in West Bloomfield, Michigan. Dr. Mahdi has been practicing medicine for over 22 years and is rated as an Experienced provider by MediFind in Gastrostomy. His top areas of expertise are Endometrial Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, Lymphadenectomy, and Endoscopy. Dr. Mahdi is currently accepting new patients.

His clinical research consists of co-authoring 101 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Kufa University College Of Medicine, 2004
Residency
University of Washington School of Medicine
Specialties
Oncology
Licenses
Obstetrics & Gynecology in MI
Board Certifications
American Board Of Obstetrics And Gynecology
American Board Of Obstetrics And Gynecology
Fellowships
Cleveland Clinic
Hospital Affiliations
Corewell Health William Beaumont University Hospital
Corewell Health Beaumont Troy Hospital
Corewell Health Dearborn Hospital
Corewell Health Wayne Hospital
Corewell Health Trenton Hospital
Corewell Health Farmington Hills Hospital
Languages Spoken
English
Arabic
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Amal Gynecologic Oncology Clinic
2300 Haggerty Road, West Bloomfield, MI 48323
Call: 313-300-1492
Other Locations
Haider Mahdi
1848 Biddle Avenue, Wyandotte, MI 48192
Call: 313-300-1492

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Randomized Phase II Trial of Nivolumab and Ipilimumab Compared to Nivolumab Monotherapy in Patients With Deficient Mismatch Repair System Recurrent Endometrial Carcinoma
A Randomized Phase II Trial of Nivolumab and Ipilimumab Compared to Nivolumab Monotherapy in Patients With Deficient Mismatch Repair System Recurrent Endometrial Carcinoma
Enrollment Status: Recruiting
Publish Date: December 17, 2025
Intervention Type: Procedure, Biological
Study Drugs: Ipilimumab, Nivolumab
Study Phase: Phase 2
Phase I/Ib Trial Evaluating the Safety and Efficacy of BET Inhibitor, ZEN003694 With PD-1 Inhibitor, Nivolumab With or Without CTLA-4 Inhibitor, Ipilimumab in Solid Tumors
Phase I/Ib Trial Evaluating the Safety and Efficacy of BET Inhibitor, ZEN003694 With PD-1 Inhibitor, Nivolumab With or Without CTLA-4 Inhibitor, Ipilimumab in Solid Tumors
Enrollment Status: Recruiting
Publish Date: October 09, 2025
Intervention Type: Procedure, Biological, Drug
Study Drugs: BET Bromodomain Inhibitor ZEN-3694, Ipilimumab, Nivolumab
Study Phase: Phase 1
Phase ll Study of a BET Inhibitor, ZEN003694, Combined With a PARP Inhibitor, Talazoparib, in Patients With Recurrent Ovarian Cancer
Phase ll Study of a BET Inhibitor, ZEN003694, Combined With a PARP Inhibitor, Talazoparib, in Patients With Recurrent Ovarian Cancer
Enrollment Status: Recruiting
Publish Date: June 22, 2025
Intervention Type: Drug
Study Drugs: ZEN003694, Talazoparib
Study Phase: Phase 2
The Efficacy of T-regulatory Cell Depletion with E7777 Combined with Immune Checkpoint Inhibitor, Pembrolizumab, in Recurrent or Metastatic Solid Tumors: Phase I/II Study
The Efficacy of T-regulatory Cell Depletion with E7777 Combined with Immune Checkpoint Inhibitor, Pembrolizumab, in Recurrent or Metastatic Solid Tumors: Phase I/II Study
Enrollment Status: Recruiting
Publish Date: December 05, 2024
Intervention Type: Drug
Study Drugs: Pembrolizumab, E7777
Study Phase: Phase 1/Phase 2
A Phase 1 Study of Pembrolizumab (MK-3475) in Combination With Recombinant Interleukin-12 in Patients With Solid Tumors
A Phase 1 Study of Pembrolizumab (MK-3475) in Combination With Recombinant Interleukin-12 in Patients With Solid Tumors
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Procedure, Biological
Study Phase: Phase 1
A Phase 2 Study Evaluating the Efficacy and Safety of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial, Epithelial Ovarian Cancer, or Carcinosarcoma
A Phase 2 Study Evaluating the Efficacy and Safety of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial, Epithelial Ovarian Cancer, or Carcinosarcoma
Enrollment Status: Completed
Publish Date: August 01, 2025
Intervention Type: Drug
Study Drugs: Paclitaxel, DKN-01
Study Phase: Phase 2
Open Label Phase 2 Study of Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With a Safety Run-in of a Dose-Dense Regimen
Open Label Phase 2 Study of Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With a Safety Run-in of a Dose-Dense Regimen
Enrollment Status: Completed
Publish Date: May 06, 2023
Intervention Type: Drug
Study Drug: Tisotumab vedotin
Study Phase: Phase 2
Pembrolizumab With Sitravatinib in Recurrent Endometrial Cancer and Other Solid Tumors With Deficient Mismatch Repair System Post PD1 Exposure: Phase II Trial
Pembrolizumab With Sitravatinib in Recurrent Endometrial Cancer and Other Solid Tumors With Deficient Mismatch Repair System Post PD1 Exposure: Phase II Trial
Enrollment Status: Withdrawn
Publish Date: February 27, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Patients With Platinum-Resistant Ovarian Cancer (MOONSTONE)
A Phase 2 Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Patients With Platinum-Resistant Ovarian Cancer (MOONSTONE)
Enrollment Status: Terminated
Publish Date: September 10, 2022
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

101 Total Publications

All-cause mortality and neighborhood social vulnerability among women with ovarian cancer.
All-cause mortality and neighborhood social vulnerability among women with ovarian cancer.
Journal: Gynecologic oncology
Published: January 21, 2025
View All 101 Publications
Similar Doctors
Experienced in Gastrostomy
Dr. Ammar W. Sukari
Oncology
Experienced in Gastrostomy
Dr. Ammar W. Sukari
Oncology

Karmanos Cancer Institute - Detroit Headquarters

4100 John R Street, 
Detroit, MI 
 (24.0 miles away)
800-527-6266
Experience:
27+ years
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients

Ammar Sukari is an Oncologist in Detroit, Michigan. Dr. Sukari has been practicing medicine for over 27 years and is rated as a Distinguished provider by MediFind in Gastrostomy. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Laryngeal Cancer, and Gastrostomy. Dr. Sukari is currently accepting new patients.

Experienced in Gastrostomy
Dr. Bhadresh D. Nayak
Oncology
Experienced in Gastrostomy
Dr. Bhadresh D. Nayak
Oncology

Bhadresh Nayak, MD

43243 Schoenherr Road, 
Sterling Heights, MI 
 (22.3 miles away)
586-268-3100
Experience:
40+ years
Languages Spoken:
English, Gujarati , Hindi
See accepted insurances
Accepting New Patients

Bhadresh Nayak is an Oncologist in Sterling Heights, Michigan. Dr. Nayak has been practicing medicine for over 40 years and is rated as a Distinguished provider by MediFind in Gastrostomy. His top areas of expertise are Myelodysplastic Syndrome (MDS), Lung Cancer, Pleuropulmonary Blastoma, Bone Marrow Aspiration, and Gastrostomy. Dr. Nayak is currently accepting new patients.

Experienced in Gastrostomy
Dr. Richard P. Zekman
Oncology
Experienced in Gastrostomy
Dr. Richard P. Zekman
Oncology

Oakland Medical Group - Division Of Clinical Hematology & Medical Oncology - Royal Oak

3577 West 13 Mile Road, Suite 310, 
Royal Oak, MI 
 (12.8 miles away)
248-551-2446
Experience:
23+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Richard Zekman is an Oncologist in Royal Oak, Michigan. Dr. Zekman has been practicing medicine for over 23 years and is rated as a Distinguished provider by MediFind in Gastrostomy. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Paget Disease of the Breast, Bone Marrow Aspiration, and Endoscopy. Dr. Zekman is currently accepting new patients.

VIEW MORE GASTROSTOMY DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mahdi's expertise for a condition
ConditionClose
  • Elite
  • Endometrial Cancer
    Dr. Mahdi is
    Elite
    . Learn about Endometrial Cancer.
    See more Endometrial Cancer experts
  • Ovarian Cancer
    Dr. Mahdi is
    Elite
    . Learn about Ovarian Cancer.
    See more Ovarian Cancer experts
  • Distinguished
  • Cervical Cancer
    Dr. Mahdi is
    Distinguished
    . Learn about Cervical Cancer.
    See more Cervical Cancer experts
  • Malignant Mixed Mullerian Tumor
    Dr. Mahdi is
    Distinguished
    . Learn about Malignant Mixed Mullerian Tumor.
    See more Malignant Mixed Mullerian Tumor experts
  • Ovarian Carcinosarcoma
    Dr. Mahdi is
    Distinguished
    . Learn about Ovarian Carcinosarcoma.
    See more Ovarian Carcinosarcoma experts
  • Sertoli-Leydig Cell Tumor
    Dr. Mahdi is
    Distinguished
    . Learn about Sertoli-Leydig Cell Tumor.
    See more Sertoli-Leydig Cell Tumor experts
  • Advanced
  • Adult Soft Tissue Sarcoma
    Dr. Mahdi is
    Advanced
    . Learn about Adult Soft Tissue Sarcoma.
    See more Adult Soft Tissue Sarcoma experts
  • Lymphadenectomy
    Dr. Mahdi is
    Advanced
    . Learn about Lymphadenectomy.
    See more Lymphadenectomy experts
  • Pseudomyxoma Peritonei
    Dr. Mahdi is
    Advanced
    . Learn about Pseudomyxoma Peritonei.
    See more Pseudomyxoma Peritonei experts
  • Testicular Yolk Sac Tumor
    Dr. Mahdi is
    Advanced
    . Learn about Testicular Yolk Sac Tumor.
    See more Testicular Yolk Sac Tumor experts
  • Vaginal Cancer
    Dr. Mahdi is
    Advanced
    . Learn about Vaginal Cancer.
    See more Vaginal Cancer experts
  • Virilizing Ovarian Tumor
    Dr. Mahdi is
    Advanced
    . Learn about Virilizing Ovarian Tumor.
    See more Virilizing Ovarian Tumor experts
View All 7 Advanced Conditions
  • Experienced
  • Agranulocytosis
    Dr. Mahdi is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
  • Angiomyoma
    Dr. Mahdi is
    Experienced
    . Learn about Angiomyoma.
    See more Angiomyoma experts
  • Bladder Reconstruction
    Dr. Mahdi is
    Experienced
    . Learn about Bladder Reconstruction.
    See more Bladder Reconstruction experts
  • Desmoplastic Small Round Cell Tumor
    Dr. Mahdi is
    Experienced
    . Learn about Desmoplastic Small Round Cell Tumor.
    See more Desmoplastic Small Round Cell Tumor experts
  • Diethylstilbestrol Syndrome
    Dr. Mahdi is
    Experienced
    . Learn about Diethylstilbestrol Syndrome.
    See more Diethylstilbestrol Syndrome experts
  • Endoscopy
    Dr. Mahdi is
    Experienced
    . Learn about Endoscopy.
    See more Endoscopy experts
View All 13 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.